The PTP4A3 inhibitor KVX-053 reduces Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virulence, inflammation, and development of acute lung injury in K18-hACE2 mice
| Title: | The PTP4A3 inhibitor KVX-053 reduces Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virulence, inflammation, and development of acute lung injury in K18-hACE2 mice |
|---|---|
| Authors: | Colunga-Biancatelli, Ruben M. L.Aff1, Aff2, IDs12931025033499_cor1; Solopov, Pavel A.Aff1; Woodson, Caitlin M.Aff3, Aff4; Allen, Irving CoyAff3, Aff4; Akhrymuk, IvanAff3, Aff4; Akhrymuk, MarynaAff3, Aff4; Heath, Brittany N.Aff3, Aff4; Ivester, Hannah M.Aff5; Day, TierneyAff1; Austin, Dan E.Aff6; Kehn-Hall, KyleneAff3, Aff4; Lazo, John S.Aff7, Aff8; Sharlow, Elizabeth R.Aff7, Aff8; Catravas, John D.Aff1, Aff2, Aff9 |
| Source: | Respiratory Research. 26(1) |
| Database: | Springer Nature Journals |